Your browser doesn't support javascript.
loading
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
Allen, Mariet; Wang, Xue; Burgess, Jeremy D; Watzlawik, Jens; Serie, Daniel J; Younkin, Curtis S; Nguyen, Thuy; Malphrus, Kimberly G; Lincoln, Sarah; Carrasquillo, Minerva M; Ho, Charlotte; Chakrabarty, Paramita; Strickland, Samantha; Murray, Melissa E; Swarup, Vivek; Geschwind, Daniel H; Seyfried, Nicholas T; Dammer, Eric B; Lah, James J; Levey, Allan I; Golde, Todd E; Funk, Cory; Li, Hongdong; Price, Nathan D; Petersen, Ronald C; Graff-Radford, Neill R; Younkin, Steven G; Dickson, Dennis W; Crook, Julia R; Asmann, Yan W; Ertekin-Taner, Nilüfer.
Afiliação
  • Allen M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Wang X; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
  • Burgess JD; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Watzlawik J; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Serie DJ; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
  • Younkin CS; Division of Information Technology, Mayo Clinic, Jacksonville, FL, USA.
  • Nguyen T; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Malphrus KG; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Lincoln S; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Carrasquillo MM; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Ho C; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Chakrabarty P; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
  • Strickland S; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Swarup V; Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Geschwind DH; Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Seyfried NT; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Dammer EB; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Lah JJ; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Levey AI; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Golde TE; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
  • Funk C; Institute for Systems Biology, Seattle, WA, USA.
  • Li H; Institute for Systems Biology, Seattle, WA, USA.
  • Price ND; Institute for Systems Biology, Seattle, WA, USA.
  • Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Younkin SG; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Crook JR; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
  • Asmann YW; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
  • Ertekin-Taner N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Electronic address: taner.nilufer@mayo.edu.
Alzheimers Dement ; 14(3): 352-366, 2018 03.
Article em En | MEDLINE | ID: mdl-29107053
ABSTRACT

INTRODUCTION:

Comparative transcriptome analyses in Alzheimer's disease (AD) and other neurodegenerative proteinopathies can uncover both shared and distinct disease pathways.

METHODS:

We analyzed 940 brain transcriptomes including patients with AD, progressive supranuclear palsy (PSP; a primary tauopathy), and control subjects.

RESULTS:

We identified transcriptional coexpression networks implicated in myelination, which were lower in PSP temporal cortex (TCX) compared with AD. Some of these associations were retained even after adjustments for brain cell population changes. These TCX myelination network structures were preserved in cerebellum but they were not differentially expressed in cerebellum between AD and PSP. Myelination networks were downregulated in both AD and PSP, when compared with control TCX samples.

DISCUSSION:

Downregulation of myelination networks may underlie both PSP and AD pathophysiology, but may be more pronounced in PSP. These data also highlight conservation of transcriptional networks across brain regions and the influence of cell type changes on these networks.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Encéfalo / Doença de Alzheimer / Transcriptoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Alzheimers Dement Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Encéfalo / Doença de Alzheimer / Transcriptoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Alzheimers Dement Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos